EGFR and cancer: The results showed that pathways that are enriched with hub genes are pathways in cancer, PI3K-Akt signaling pathway, MicroRNAs in cancer, EGFR tyrosine kinase inhibitor resistance, and Proteoglycans in cancer (Table 4).